Stock Rich List
#3272 on the rich list of 14,452 insiders

Enrique Poradosu

Chief Science & Business Off at Nuvectis Pharma. Based in Fort Lee, New Jersey.

$35.8M
in disclosed stock, −$813K (−2.22%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
3272nd of 14,452
Companies held
1
Largest holding
NVCT, 100.0% of total
Latest SEC filing
Jan 6, 2026

What the $35.8M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Nuvectis Pharma NVCT
Common Stock
Directly1,806,319$19.84$35.8M100.0%Form 4, Jan 6, 2026

Share counts are the amounts Enrique Poradosu reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
3269Lara Caimi
SEE REMARKS, Samsara. Pittsburgh, PA
$35.9M−$1.4M (−3.69%)
3270Rohit Gupta
President and CEO, Enact Holdings. Raleigh, NC
$35.8M−$728K (−1.99%)
3271Ashish Bhutani
CEO of Lazard Asset Management, Lazard. Los Angeles, CA
$35.8M−$1.6M (−4.35%)
3272Enrique Poradosu
Chief Science & Business Off, Nuvectis Pharma. Fort Lee, NJ
$35.8M−$813K (−2.22%)
3273Barry A. Hytinen
EVP and CFO, Iron Mountain. Portsmouth, NH
$35.8M−$984K (−2.68%)
3274Thomas Caulfield
Director, Sandisk. Milpitas, CA
$35.8M−$432K (−1.19%)
3275Gaurav Anand
Chief Financial Officer, Coupang. Seattle, WA
$35.8M−$559K (−1.54%)

Other Nuvectis Pharma insiders

All NVCT insiders

Questions

How much stock does Enrique Poradosu own?

Enrique Poradosu holds $35,837,369 in listed stock based on SEC filings and current prices, mostly Nuvectis Pharma (NVCT). That ranks 3272nd on the Stock Rich List.

Is this Enrique Poradosu's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.